The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients ...
Currently, the world is suffering from environmental problems caused by plastic waste. A KAIST research team has succeeded in ...
The U.S. Food and Drug Administration approved PTC Therapeutics' gene therapy to treat a potential fatal enzyme deficiency ...
The treatment is the first approved gene therapy for AADC deficiency, the FDA said. People with this rare disorder have ...
In this communication evidence is presented of transamination of aromatic amino-acids in the nervous tissues, that is, rat brain extracts.
A team led by Distinguished Professor Sang Yup Lee of the Department of Chemical and Biomolecular Engineering has succeeded ...
The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...
The approval marks the first time gene therapy will be available to treat patients with aromatic I-amino acid decarboxylase ...
The drug is a treatment for a rare and fatal genetic disorder called aromatic l-amino acid decarboxylase (AADC) deficiency, ...
An invaluable text for synthetic chemists in the pharmaceutical, agrochemical, plastic and detergent industries, this book provides a detailed, up-to-date account of the reactions of chlorosulfonic ...
Researchers have succeeded in developing a microbial strain that efficiently produces pseudoaromatic polyester monomer to replace polyethylene terephthalate (PET) using systems metabolic engineering.